Acadia Healthcare (NASDAQ:ACHC) Sets New 1-Year High – Here’s Why

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) hit a new 52-week high during trading on Wednesday . The stock traded as high as $30.71 and last traded at $30.5560, with a volume of 370087 shares trading hands. The stock had previously closed at $29.53.

Analysts Set New Price Targets

Several research firms have issued reports on ACHC. TD Cowen increased their price objective on Acadia Healthcare from $24.00 to $30.00 and gave the stock a “buy” rating in a research note on Tuesday, April 28th. Royal Bank Of Canada upped their target price on shares of Acadia Healthcare from $28.00 to $31.00 and gave the stock an “outperform” rating in a report on Monday, May 4th. KeyCorp reissued an “overweight” rating and set a $30.00 price target on shares of Acadia Healthcare in a report on Wednesday, May 27th. Jefferies Financial Group upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their price target for the company from $24.50 to $30.00 in a research report on Wednesday, June 3rd. Finally, Raymond James Financial raised shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price objective for the company in a report on Monday, May 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $26.85.

Acadia Healthcare Stock Performance

The stock has a 50 day moving average price of $25.47 and a two-hundred day moving average price of $20.92. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.71. The company has a market capitalization of $2.80 billion, a price-to-earnings ratio of -2.48, a price-to-earnings-growth ratio of 9.24 and a beta of 0.69.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.09. The business had revenue of $828.80 million for the quarter, compared to the consensus estimate of $823.51 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The firm’s quarterly revenue was up 7.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.40 EPS. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, analysts predict that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. EverSource Wealth Advisors LLC lifted its holdings in Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after buying an additional 497 shares in the last quarter. Wells Fargo & Company MN lifted its stake in shares of Acadia Healthcare by 208.9% during the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after acquiring an additional 1,510 shares during the period. Bayforest Capital Ltd bought a new position in Acadia Healthcare in the fourth quarter valued at about $52,000. GAMMA Investing LLC increased its position in Acadia Healthcare by 124.7% in the fourth quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock worth $69,000 after purchasing an additional 2,698 shares during the period. Finally, Caitong International Asset Management Co. Ltd raised its holdings in Acadia Healthcare by 4,264.8% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock worth $76,000 after purchasing an additional 5,203 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.